Cited by 24Alzheimer's disease research and treatmentsBarrier Structure and Function StudiesNeuroinflammation and Neurodegeneration Mechanisms

Differential gene expression in human brain pericytes induced by amyloid‐β protein

Rensink, A. A. M., Otte‐Höller, I., Donkelaar, H. J. ten, De Waal, R. M. W., Kremer, B., Verbeek, M. M.·2004·Neuropathology and Applied Neurobiology

Abstract

Cerebral amyloid angiopathy is one of the characteristics of Alzheimer's disease (AD) and this accumulation of fibrillar amyloid-beta (Alphabeta) in the vascular wall is accompanied by marked vascular damage. In vitro, Abeta1-40 carrying the 'Dutch' mutation (DAbeta1-40) induces degeneration of cultured human brain pericytes (HBP). To identify possible intracellular mediators of Abeta-induced cell death, a comparative cDNA expression array was performed to detect differential gene expression of Abeta-treated vs. untreated HBP. Messenger RNA expression of cyclin D1, integrin beta4, defender against cell death-1, neuroleukin, thymosin beta10, and integrin alpha5 were increased in DAbeta1-40-treated HBP, whereas insulin-like growth factor binding protein-2 mRNA expression was decreased. Corresponding protein expression was investigated in AD and control brains to explore a potential role for these proteins in pathological lesions of the AD brain. Cyclin D1 expression was increased in cerebral amyloid angiopathy and cells in a perivascular position, suggesting that the cell cycle may be disturbed during Abeta-mediated degeneration of cerebrovascular cells. Moreover, cyclin D1 expression, but also that of integrin beta4, defender against cell death-1, neuroleukin and thymosin beta10 was found in a subset of senile plaques, suggesting a role for these proteins in the pathogenesis of senile plaques.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2990.2004.00536.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rensink, A. A. M., Otte‐Höller, I., Donkelaar, H. J. T., De Waal, R. M. W., Kremer, B., & Verbeek, M. M.
Corresponding author
Verbeek, M. M.
Venue
Neuropathology and Applied Neurobiology
Publisher
Wiley
Published
2004-02-06
Volume
30
Issue
3
Pages
279-291
ISSN
  • 0305-1846 (ISSN-L)
  • 1365-2990
OpenAlex
W2021956333
Cited by
24
References
2
Citations by year
2026: 1 · 2025: 1 · 2024: 6 · 2021: 1 · 2020: 2 · 2019: 1 · 2018: 1 · 2015: 1 · 2013: 1 · 2012: 1
FWCI
1.44
Type
journal article
Language
en
Open access
closed
Locations
  • Neuropathology and Applied Neurobiology (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Funders
  • Barbara Ann Karmanos Cancer Institute
  • Chinese Academy of Agricultural Sciences
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
amyloid-beta, cerebral amyloid angiopathy, Alzheimer's disease, differential gene expression, pericyte degeneration, cyclin D1, ITGB4, neuroleukin, integrin alpha5, IGFBP-2, amyloid plaques, perivascular cells, cell cycle
MeSH terms
Alzheimer Disease, Brain Chemistry, Cells, Cultured, Cerebral Cortex, Fluorescent Antibody Technique, Humans, Immunohistochemistry, Nerve Tissue Proteins, Gene Expression, Amyloid beta-Peptides, DNA, Complementary, Pericytes, Oligonucleotide Array Sequence Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review